All of modern medicine is dependent on advances in chemistry and the healthcare goalposts have moved as the century has turned. We all face problems with the spreading of infectious disease on an unprecedented scale. Poorer nations struggle to afford or distribute expensive modern drugs, while in all nations drug resistance is growing. The exponentially increasing prevalence of non-infectious disease in an ageing population brings unforeseen and expensive challenges to healthcare.
Often the challenges to developing better healthcare lie in a lack of basic molecular-level understanding of the disease biology, a lack of sufficiently advanced tools and methods to detect and treat disease and to validate drug targets, or a lack of an arsenal of small and large molecules to engage drug targets thereby ameliorating diseases.
These are all challenges that chemical science research can contribute to overcome. By developing new biochemical tools to detect disease earlier, and more sensitive detection methods to monitor disease more closely, scientists will enable quicker diagnosis and more effective, less invasive monitoring of disease. Furthermore, equipped by modern synthetic methods and computational modelling based on structural biology, medicinal chemists are able to craft potent, selective and safe molecules to interact with biological targets, and turn them into drugs in collaboration with colleagues of other disciplines.
Roche and the RSC are committed to improving the standards of healthcare for people worldwide and have partnered to host a series of symposia in China on tackling medical issues through innovative and interdisciplinary chemical research. This two-day scientific symposium will seek to highlight the latest chemistry and chemical biology research that could enable drug discovery and development. With 8 outstanding young Chinese scholars, also the Roche Chinese Young Investigator Awardees, the first-day symposium will focus on pioneering research on topics in the fields of asymmetric catalysis, cross-coupling reactions, hetereocycle synthesis, and chemical and structural biology, particularly related to infectious diseases. The second-day symposium will showcase several case studies of drug or drug candidate molecules by industrial experts in drug discovery, and the vision sharing regarding how chemical research could impact drug discovery.
Often the challenges to developing better healthcare lie in a lack of basic molecular-level understanding of the disease biology, a lack of sufficiently advanced tools and methods to detect and treat disease and to validate drug targets, or a lack of an arsenal of small and large molecules to engage drug targets thereby ameliorating diseases.
These are all challenges that chemical science research can contribute to overcome. By developing new biochemical tools to detect disease earlier, and more sensitive detection methods to monitor disease more closely, scientists will enable quicker diagnosis and more effective, less invasive monitoring of disease. Furthermore, equipped by modern synthetic methods and computational modelling based on structural biology, medicinal chemists are able to craft potent, selective and safe molecules to interact with biological targets, and turn them into drugs in collaboration with colleagues of other disciplines.
Roche and the RSC are committed to improving the standards of healthcare for people worldwide and have partnered to host a series of symposia in China on tackling medical issues through innovative and interdisciplinary chemical research. This two-day scientific symposium will seek to highlight the latest chemistry and chemical biology research that could enable drug discovery and development. With 8 outstanding young Chinese scholars, also the Roche Chinese Young Investigator Awardees, the first-day symposium will focus on pioneering research on topics in the fields of asymmetric catalysis, cross-coupling reactions, hetereocycle synthesis, and chemical and structural biology, particularly related to infectious diseases. The second-day symposium will showcase several case studies of drug or drug candidate molecules by industrial experts in drug discovery, and the vision sharing regarding how chemical research could impact drug discovery.
